Gynecologic Oncology Reports (Aug 2022)

A case of endometrial intraepithelial neoplasia in a transgender man on testosterone therapy

  • Reed M. O'Connor,
  • Marla E. Scott,
  • Rania Bakkar,
  • B.J. Rimel

Journal volume & issue
Vol. 42
p. 101031

Abstract

Read online

Testosterone is commonly used as gender-affirming therapy to induce masculinization in transmasculine individuals. The effects of testosterone therapy on endometrial tissue are complex, and while some patients experience endometrial atrophy while taking testosterone, others do not. Reports of gynecologic malignancies, and endometrial cancer in particular, in transmasculine patients taking testosterone are extremely rare (Urban et al., May 2011; Jeevananthan and Iyengar, 2021; Agnieszka Bobola, 2021). Here we report a case of endometrial intraepithelial neoplasia in a transgender man taking testosterone.

Keywords